Skip To Content
Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site
Geographic Differences in Substance Abuse Treatment Admissions
for Methamphetamine / Amphetamine and Marijuana: 2005

The DASIS Report:  Geographic Differences in Substance Abuse Treatment Admissions for Methamphetamine / Amphetamine and Marijuana: 2005

  • HTML format (also has the data table used to construct each figure)

Highlights:

  • Among the six primary substances of abuse that dominate substance abuse treatment admissions reported to SAMHSA's Treatment Episode Data Set (TEDS), three (marijuana, methamphetamine/amphetamines, and opiates other than heroin) increased between 1995 and 2005 and three decreased (alcohol, cocaine, and heroin). All the rates presented are for substance abuse treatment admissions with methamphetamine/amphetamines or marijuana as their primary substance of abuse. The full report contains maps indicating the relative quintile rank of each State.

    Methamphetamine/Amphetamine Treatment Admissions:

  • The methamphetamine/amphetamine treatment admission rate for the nation increased from 30 per 100,000 population aged 12 or older in 1995 to 68 per 100,000 in 2005.
  • Generally, in both 1995 and 2005, the Pacific and Mountain States had the highest rates for substance abuse treatment admissions whose primary drug was methamphetamine/ amphetamines.
  • In 1995, Oregon alone had a methamphetamine/amphetamine treatment admission rate of 220 or more per 100,000. By 2005, four States (Hawaii, Iowa, Oregon, and Washington) had a methamphetamine/ amphetamine treatment admission rate of 220 or more per 100,000.
  • In 2005, the States with the lowest rates of methamphetamine/amphetamine treatment admissions (less than 5 per 100,000) were Connecticut, Maryland, Massachusetts, New Jersey, New York, Pennsylvania, and Rhode Island.

    Marijuana Treatment Admissions:

  • The marijuana treatment admission rate for the nation increased from 81 per 100,000 population aged 12 or older in 1995 to 118 per 100,000 in 2005.
  • Generally, in both 1995 and 2005, the West North Central and Pacific had the highest rates for substance abuse treatment admissions whose primary drug was marijuana.
  • In 1995, Iowa alone had a marijuana treatment admission rate of 199 or more per 100,000. By 2005, seven States (Delaware, Iowa, Missouri, New York, Oregon, South Dakota, and Vermont) had a marijuana treatment admission rate of 199 or more per 100,000.

This Short Report, The DASIS Report:  Geographic Differences in Substance Abuse Treatment Admissions for Methamphetamine / Amphetamine and Marijuana: 2005, is based on the Drug and Alcohol Services Information System (DASIS), the primary source of national data on substance abuse treatment.  DASIS is conducted by the Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA).  

This is the page footer.

This page has been accessed 30279 times since 1/22/08.

This page was last updated on January 22, 2008.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

Yellow Line

Site Map | Contact Us | Accessibility Privacy PolicyFreedom of Information ActDisclaimer  |  Department of Health and Human ServicesSAMHSAWhite HouseUSA.gov

* Adobe™ PDF and MS Office™ formatted files require software viewer programs to properly read them. Click here to download these FREE programs now

What's New

Highlights Topics Data Drugs Pubs Short Reports Treatment Help Mail OAS